3-n-methylspiperone has been researched along with rolipram in 1 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (rolipram) | Trials (rolipram) | Recent Studies (post-2010) (rolipram) |
---|---|---|---|---|---|
155 | 6 | 7 | 1,604 | 17 | 401 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gee, A; Hosoi, R; Inoue, O; Ishikawa, M; Kobayashi, K; Yamaguchi, M | 1 |
1 other study(ies) available for 3-n-methylspiperone and rolipram
Article | Year |
---|---|
Effects of rolipram on in vivo dopamine receptor binding.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Binding Sites; Brain; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mice; Neurons; Phosphodiesterase Inhibitors; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rolipram; Spiperone | 2002 |